EUVIMEDEUVIMED entdecken
Validierungsstudie

Revealing the active ingredients and mechanisms of Xiatianwu against hepatocellular carcinoma: a study based on network pharmacology and bioinformatics

Hui Wang iD, Weina Zhang, Liling Li, Hong Wang, Honglin Jiang, Wenna Li, Jinchang Huang, Yuxiang Wan

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025

DOI: 10.1007/s00210-024-03278-2 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Hui Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing, 100029, China. Hauptthemen laut MEDLINE: Bicuculline, Corydalis, Drugs, Chinese Herbal, Network Pharmacology. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: the Natural Science Foundation of China, Project of Beijing University of Chinese Medicine, Project of the China Association of Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BicucullineCorydalisDrugs, Chinese HerbalNetwork PharmacologyAntineoplastic Agents, PhytogenicHumansCarcinoma, HepatocellularCell CycleCell MovementComputational BiologyGene Expression ProfilingHep G2 CellsLiver NeoplasmsMolecular Docking Simulation

Stichwörter der Autor:innen

BicucullineBioinformaticsHepatocellular carcinomaNetwork pharmacologyXiatianwu (Rhizoma Corydalis Decumbentis)

Substanzen

BicucullineDrugs, Chinese HerbalAntineoplastic Agents, Phytogenic

Autor:innen und Institutionen

  • Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing, 100029, China.
  • Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, China.
  • Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing, 100029, China. zryhhuang@163.com.
  • Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing, 100029, China. wanyuxiang@bucm.edu.cn.

ORCID-Profile: Hui Wang

Förderung

  • the Natural Science Foundation of China
  • Project of Beijing University of Chinese Medicine
  • Project of the China Association of Chinese Medicine

Zitieren

APA

Wang, H., Zhang, W., Li, L., Wang, H., Jiang, H., Li, W., Huang, J., & Wan, Y. (2025). Revealing the active ingredients and mechanisms of Xiatianwu against hepatocellular carcinoma: a study based on network pharmacology and bioinformatics. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-024-03278-2

Vancouver

Wang H, Zhang W, Li L, Wang H, Jiang H, Li W, et al. Revealing the active ingredients and mechanisms of Xiatianwu against hepatocellular carcinoma: a study based on network pharmacology and bioinformatics. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-024-03278-2

BibTeX
@article{Wang2025,
  author = {Wang, Hui and Zhang, Weina and Li, Liling and Wang, Hong and Jiang, Honglin and Li, Wenna and Huang, Jinchang and Wan, Yuxiang},
  title = {Revealing the active ingredients and mechanisms of Xiatianwu against hepatocellular carcinoma: a study based on network pharmacology and bioinformatics},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  doi = {10.1007/s00210-024-03278-2}
}
Kostenlos starten →